A new study finds anifrolumab (Saphnelo) may reduce harmful inflammation and improve signs of overall immune health.

Lupus Canada awarded the 2026 Lupus Canada Catalyst Grant to Andrea Knight, MD, MSCE, Associate Professor, Division of Rheumatology and Associate Scientist, Neurosciences and Mental Health, The ...

Researchers investigated belimumab's (Benlysta®) effect on low platelet (thrombocytopenia) and low white blood cell ...

The House Appropriations Committee has approved the Fiscal Year 2027 Defense Appropriations bill, which includes $10 million ...

The Lupus Foundation of America (LFA) is proud to announce Reeve Bright as the top fundraiser of the LFA’s inaugural Men on a Mission™ campaign.

Join the Lupus Foundation of America for our 2026 National Summer Support Event — a casual summer-themed virtual gathering ...

This Father’s Day, we’re celebrating the fathers in the lupus community who show up every day, not always in the ways they ...

The Lancet has published the positive full results ofUCB and Biogen’s Phase III PHOENYCS GO study of dapirolizumab pegol (DZP), an investigational, novel Fc-free CD40L inhibitor, for people with ...

A new study looked at whether heart scan results can help predict serious cardiovascular or cerebrovascular (brain) events (MACCE) in people with systemic lupus erythematosus (SLE) and found a ...

Last night at the 2026 Oscars, comedian Conan O’Brien made a joke during a skit to open the show that negatively associated his appearance with make-up to having lupus. Using lupus as a punchline, ...

The Novartis research study is testing a potential new investigational treatment that is a single infusion of rapcabtagene autoleucel (also called rap-cel) for patients with active, refractory lupus ...

The U.S. Food and Drug Administration (FDA) has granted Johnson & Johnson’s, nipocalimab, Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). This ...